Exploration of the diagnostic utility of next generation sequencing with TruSight cancer panel for BRCA negative hereditary breast and ovarian cancer patients

被引：0
|
作者：
Dacheva, D.
Dodova, R.
Mitkova, A.
Kamenarova, K.
Tzveova, R.
Popov, I.
Vlahova, A.
Taushanova-Hadjieva, M.
Valev, S.
Dikov, T.
Timcheva, K.
Christova, S.
Mitev, V.
Kaneva, R.
机构：
[1] Med Univ Sofia, Fac Med, Mol Med Ctr, Sofia, Bulgaria
[2] Med Univ Sofia, Univ Hosp Alexandrovska, Gen & Clin Pathol Clin, Sofia, Bulgaria
[3] Nadezhda Womens Hlth Hosp, Clin Med Oncol Chemotherapy, Sofia, Bulgaria
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.SABCS15-P2-09-18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-09-18
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies
    Piera Rizzolo
    Valentina Silvestri
    Laura Ottini
    Breast Cancer Research and Treatment, 2017, 162 : 199 - 200
  • [22] Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients Clinical Testing with a Multigene Test Panel
    Kwong, Ava
    Shin, Vivian Y.
    Chen, Jiawei
    Cheuk, Isabella W. Y.
    Ho, Cecilia Y. S.
    Au, Chun H.
    Chan, Karen K. L.
    Ngan, Hextan Y. S.
    Chan, Tsun L.
    Ford, James M.
    Ma, Edmond S. K.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (04): : 544 - 554
  • [23] Risk of ovarian cancer in BRCA1 and BRCA2 mutation negative hereditary breast cancer families
    Kauff, ND
    Mitra, N
    Robson, ME
    Hurley, KE
    Chuai, S
    Goldfrank, D
    Wadsworth, E
    Lee, J
    Cigler, T
    Borgen, PI
    Norton, L
    Barakat, RR
    Offit, K
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18): : 1382 - 1384
  • [24] Multiple cancer susceptible genes sequencing in BRCA-negative breast cancer with high hereditary risk
    Lang, Guan-Tian
    Shi, Jin-Xiu
    Huang, Liang
    Cao, A-Yong
    Zhang, Chen-Hui
    Song, Chuan-Gui
    Zhuang, Zhi-Gang
    Hu, Xin
    Huang, Wei
    Shao, Zhi-Ming
    ANNALS OF TRANSLATIONAL MEDICINE, 2020, 8 (21)
  • [25] Mutations of BRCA genes in hereditary breast and ovarian cancer
    Radice, P
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2002, 21 (03) : 9 - 12
  • [26] Next-generation sequencing of BRCA1 and BRCA2 in breast cancer patients and control subjects
    Balabanski, Lubomir
    Antov, Georgi
    Dimova, Ivanka
    Ivanov, Samuil
    Nacheva, Maria
    Gavrilov, Ivan
    Nesheva, Desislava
    Rukova, Blaga
    Hadjidekova, Savina
    Malinov, Maxim
    Toncheva, Draga
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (03) : 435 - 439
  • [27] Determining the accuracy of next generation sequencing based copy number variation analysis in Hereditary Breast and Ovarian Cancer
    Agaoglu, Nihat Bugra
    Unal, Busra
    Dogan, Ozlem Akgun
    Zolfagharian, Payam
    Sharifli, Pari
    Karakurt, Aylin
    Senay, Burak Can
    Kizilboga, Tugba
    Yildiz, Jale
    Doganay, Gizem Dinler
    Doganay, Levent
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (02) : 239 - 246
  • [28] Clinical Validity of Next-Generation Sequencing Multi-Gene Panel Testing for Detecting Pathogenic Variants in Patients With Hereditary Breast-Ovarian Cancer Syndrome
    Yoo, Jaeeun
    Lee, Gun Dong
    Kim, Jee Hae
    Lee, Seung Nam
    Chae, Hyojin
    Han, Eunhee
    Kim, Yonggoo
    Kim, Myungshin
    ANNALS OF LABORATORY MEDICINE, 2020, 40 (02) : 152 - 158
  • [29] Next-generation sequencing for hereditary breast and gynecologic cancer risk assessment
    Kurian, Allison W.
    Kingham, Kerry E.
    Ford, James M.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2015, 27 (01) : 23 - 33
  • [30] Cancer frequency in BRCA mutation families with hereditary breast and ovarian cancer
    Cajal, Teresa Ramon y
    Capdevila, Jaume
    Carrera, Gemma
    Villanueva, Rafael
    Puig, Teresa
    Gich, Ignasi
    Diez, Orland
    Alonso, M. Carmen
    Barnadas, Agusti
    ANNALS OF ONCOLOGY, 2006, 17 : 275 - 275
12345